23andMe Risk Test Misses Almost 90 Percent of BRCA Mutation Carriers

Image by 23andme.com
Update, 9:20 a.m.: This story has been updated with 23andMe’s response.
A recent study found that 23andMe’s direct-to-consumer BRCA test misses almost 90% of mutation carriers, GenomeWeb reported.
Researchers at Invitae, a genetic information company, led the study into 23andMe’s test, which looks for three common branches in the cancer-causing BRCA1 and BRCA2 genes. Mutations in these genes, which are often hereditary, increase the risk of breast and ovarian cancers, according to the National Cancer Institute.
The study found that the test by 23andMe, a genomics and biotechnology company, misses the majority of BRCA mutation carriers both in those with and without a personal or family history of cancer, according to GenomeWeb. It also misses almost 20% of BRCA mutations in those of Ashkenazi Jewish descent.
The study looked at data from almost 125,000 people who went to Invitae for diagnostic testing with one of the company’s cancer risk tests. The results were presented Sunday at the American College of Medical Genetics and Genomics annual meeting. The study was meant to criticize 23andMe’s screening strategy, which appeared to be flawed.
23andMe is authorized by the U.S. Food and Drug administration. In the presentation, Edward Esplin, a clinical geneticist at Invitae, brought up that the FDA actually had concerns about test, as it doesn’t check for more than 1,000 other known BRCA mutations and said that both negative and positive results could be misleading.
23andMe informs its customers that it tests for only three out of thousands variants of the BRCA1 and BRCA2 genes, said Andy Kill, in the company’s communications department. The information is also written in bold at the top of the results report.
The BRCA gene has a reputation as a “Jewish cancer gene.” Ashkenazi women are at a higher risk of testing positive for it and ultimately getting diagnosed breast and ovarian cancer.
Alyssa Fisher is a writer at the Forward. Email her at [email protected], or follow her on Twitter at @alyssalfisher
The Forward is free to read, but it isn’t free to produce

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward.
At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse.
Readers like you make it all possible. We’ve started our Passover Fundraising Drive, and we need 1,800 readers like you to step up to support the Forward by April 21. Members of the Forward board are even matching the first 1,000 gifts, up to $70,000.
This is a great time to support independent Jewish journalism, because every dollar goes twice as far.
— Rachel Fishman Feddersen, Publisher and CEO
2X match on all Passover gifts!
Most Popular
- 1
News A Jewish Republican and Muslim Democrat are suddenly in a tight race for a special seat in Congress
- 2
Film & TV What Gal Gadot has said about the Israeli-Palestinian conflict
- 3
Fast Forward The NCAA men’s Final Four has 3 Jewish coaches
- 4
Fast Forward Cory Booker proclaims, ‘Hineni’ — I am here — 19 hours into anti-Trump Senate speech
In Case You Missed It
-
News Who would protect New York Jews better? Cuomo and Lander trade attacks on the campaign trail
-
News Rabbis revolt over LGBTQ+ club, exposing fight over queer acceptance at Yeshiva University
-
Opinion In Qatargate fiasco, Netanyahu’s ‘witch hunt’ narrative takes cues from Trump
-
Yiddish די הגדה ווי אַ לעבעדיקער דענקמאָל פֿון אַשכּנזישער פּאָעזיעThe Haggadah as a living monument to Ashkenazi poetry
אַמאָל זענען די פּייטנים, מיסטישע דיכטער־וויזיאָנערן, געווען אויבן־אָן בײַ די פֿראַנצויזישע און דײַטשישע ייִדן.
-
Shop the Forward Store
100% of profits support our journalism
Republish This Story
Please read before republishing
We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:
- Credit the Forward
- Retain our pixel
- Preserve our canonical link in Google search
- Add a noindex tag in Google search
See our full guidelines for more information, and this guide for detail about canonical URLs.
To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.